Castleman Disease – how machine learning can support treatment
February 20, 2019
Combining large omic and clinical trial data sets with machine learning algorithms has allowed Medidata and CDCN to identify six new patient subgroups of rare Castleman disease. How can this discovery advance diagnostics and drug development for this rare disease? Allie Nawrat finds out.
After hearing a talk by Castleman Disease Collaborative Network co-founder Dr David Fajgenbaum as part of a lecture series about challenging topics in the life sciences, artificial intelligence firm Medidata decided to stay in touch with Fajgenbaum and his company.Medidata chief data officer David Lee explains: “One day we were talking [with Dr Fajgenbaum] about how far the [Rave Omics] product and machine learning has come, and he was telling us about how much data he has been able to collect on [Castleman disease].“Then as a proof of concept, we decided to work on this collaboration together.”Combining CDCN’s large data sets from patients suffering with this rare, inflammatory disease with Rave Omics’ machine learning capabilities has led to novel insights about the disease that help to understand which patients will respond best to existing treatments and identify new drug targets for patients responding less well. Continue reading
We may collect information using “cookies.” Cookies are small data files stored on the hard drive of your computer or mobile device by a website. We may use both session cookies (which expire once you close your web browser) and persistent cookies (which stay on your computer or mobile device until you delete them) to provide you with a more personal and interactive experience on our Site.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
Analytical cookies allow us to analyze our Site. For example, we use analytical cookies to count the number of visitors and sources of web traffic so we can see how users move around our Site when they are using it. This helps us to improve the way our Site works, for example, by ensuring that users can find what they are looking for easily. All information these cookies collect is aggregated and therefore anonymized.
Cookies are used to deliver many types of targeted digital marketing. They store user data and behavior information, which allows advertising services to target audience groups according to variables including Age, Gender, Location, Interests, behavior on your website, search engines, and social media.